Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

The Scientific Sales and Marketing Gap

Brilliant organisations like One Nucleus exist to support economic growth across the life sciences and associated sectors in the UK; whether it’s introductions to help secure investment, fostering collaboration with universities, help with recruiting the best teams to propel your venture forwards or, perhaps more importantly, providing a network of like-minded people and a forum to share best practice and bounce ideas around.

Your sales and marketing teams are an integral part of your business, but there is currently a large gap in terms of support for them.

Creative Biolabs Updates Its Antibody Array Analysis, Highlighting the New Features in Biomarker Discovery

Creative Biolabs has recently released a new version of its comprehensive antibody array analysis for biomarker discovery. This service adds to the variety of offered antibody arrays by providing more comprehensive examinations of the protein expression and its post-translational modifications, especially the phosphorylation patterns.

Biocair Announces Further Expansion in the APAC Region As Part of Global Growth Strategy

  • Biocair has opened a new office in Chengdu, China 
  • This office is its eighth office in the APAC region 
  • Biocair reaffirms its commitment to developing industry-leading global solutions for life science logistics 

26 February 2025, Cambridge, UK – Today, Biocair, an established global leader in life science logistics, announced the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.

UK Tax Implications of the Trump Administration

In just a matter of weeks since the inauguration of Donald Trump as the 47th president of the United States of America (US), he has already signed multiple executive orders, some of which could have a significant impact, not just on the US tax landscape, but on global tax policy.

Of course, many of Trump’s policy objectives were well documented through the presidential campaign, although tax policy certainly took a back seat this time around when compared to the issues debated in the run up to the 2016 US election, when Trump first took the Oval Office.

MediWales Connects Conference 2025

MediWales will be holding their annual all-Wales NHS Connects Conference on the 17th of June at the All Nations Centre in Cardiff.

NHS colleagues from across Wales, local companies and the wider industry sector will join to share clinical innovation in practice to improve patient outcomes.

The event includes presentations, workshops, exhibitions and networking.

The aims of the conference are to:

MediWales BioWales in London 2025

MediWales are holding their annual BioWales in London conference on the 12th of March 2025.
This conference will bring together industry and health to showcase Welsh innovation in life sciences, including MedTech, diagnostics and NHS collaborations. Delegates will have the chance to discuss the latest breakthroughs and advancements in these fields while exploring new opportunities for growth and collaboration.

J A Kemp Webinar: Parameters and the EPO

Parameters are generally used in patent claims to define subject matter which cannot be expressed in terms of structural features. They can be the most appropriate way to ensure that a claim scope effectively covers an inventor’s contribution. The use of parameters is common for inventions in the chemical field but they can find applicability in a wide variety of technological areas.

Cresset releases Flare™ V10, the latest update to its agile ligand and structure-based drug design platform, featuring significant scientific enhancements for computational and medicinal chemists

12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.

The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand Interaction Fingerprints (PLIF).

Subscribe to